PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Schizophrenia Research10.16946/kjsr.2021.24.2.60202124260-67Association of the First Antipsychotic Treatment Duration With the Re-Initiation of Treatment in Schizophrenia: A National Health Insurance Data-Based StudyMinho Song, Jungsun Lee, Harin Kim, Soojin Ahn, Young Jae Choi, Young Tak Jo, Sung Woo Joohttp://kjsr.org/upload/pdf/kjsr-2021-24-2-60.pdf, http://kjsr.org/journal/view.php?doi=10.16946/kjsr.2021.24.2.60, http://kjsr.org/upload/pdf/kjsr-2021-24-2-60.pdf
Psychiatry and Clinical Neurosciences10.1111/pcn.133412022765195-200Risk of treatment discontinuation and psychiatric hospitalization associated with early dose reduction of antipsychotic treatment in first‐episode schizophrenia: A nationwide, health insurance data–based studySung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Leehttps://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13341, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/pcn.13341, https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13341
European Neuropsychopharmacology10.1016/j.euroneuro.2022.03.01020225936-44Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based studySung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Leehttps://api.elsevier.com/content/article/PII:S0924977X22001687?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0924977X22001687?httpAccept=text/plain
10.21203/rs.3.rs-437463/v12021Schizophrenia Long-Acting Injectable Antipsychotic Initiation Index: A Clinician Rated Instrument for Improving Treatment in SchizophreniaPetru Ifteni, Andreea Teodorescuhttps://www.researchsquare.com/article/rs-437463/v1, https://www.researchsquare.com/article/rs-437463/v1.html
Schizophrenia Research10.1016/s0920-9964(12)70184-62012136S51EFFECTS OF RELAPSE DURATION AND ANTIPSYCHOTIC TREATMENT ON BRAIN TISSUE IN SCHIZOPHRENIANancy C. Andreasenhttps://api.elsevier.com/content/article/PII:S0920996412701846?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0920996412701846?httpAccept=text/plain
Yearbook of Psychiatry and Applied Mental Health10.1016/j.ypsy.2011.08.11220122012130-132Long-term Antipsychotic Treatment and Brain Volumes: A Longitudinal Study of First-Episode SchizophreniaR.J. Franceshttps://api.elsevier.com/content/article/PII:S0084397011002465?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084397011002465?httpAccept=text/plain
Schizophrenia Research10.1016/s0920-9964(14)70774-12014153S271Poster #M224 DURATION OF ANTIPSYCHOTIC MEDICATION TREATMENT IS A MODIFIER FOR WEIGHT GAINMaarten Bak, Jim van Oshttps://api.elsevier.com/content/article/PII:S0920996414707741?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0920996414707741?httpAccept=text/plain
Schizophrenia Research10.1016/j.schres.2007.12.09020089842-4323 – Analysis of psychiatric hospitalization after initiation of oral antipsychotic treatment for schizophreniaJ. Diels, K. Trakas, D. Nicholl, G. Nuytshttps://api.elsevier.com/content/article/PII:S0920996407006548?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0920996407006548?httpAccept=text/plain
The Brown University Psychopharmacology Update10.1002/pu.3034420182983-3Study supports continuous antipsychotic treatment for first-episode schizophreniahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpu.30344, http://onlinelibrary.wiley.com/wol1/doi/10.1002/pu.30344/fullpdf
Schizophrenia Research10.1016/j.schres.2007.12.0912008984324 – Direct healthcare costs after initiation of oral antipsychotic treatment for schizophrenia: Efficacy versus tolerabilityJ. Diels, K. Trakas, D. Nicholl, G. Nuytshttps://api.elsevier.com/content/article/PII:S092099640700655X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092099640700655X?httpAccept=text/plain